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Abstract
AIM: Measles outbreak in the immunocompromised population is a big challenge to interrupt endemic transmission. 
This study aimed to investigate of measles in pediatric oncology patients and find the reason behind the outbreak.
METHODS: A descriptive study was conducted on 11 pediatric oncology patients with measles. We collected 
demographic, epidemiological, and clinical data. Most of suspected measles cases were done measles 
immunoglobulin M test and clinical data were followed up and analyzed by SPSS.
RESULTS: From April 20, 2018, to July 10, 2019, a total of 11 patients with malignancies were notified to develop 
measles in Hue. Of these 11 patients with the median age of 4.0 years (range: 1–9 years), two patients had not 
received any dose of measles vaccine, five patients received two doses, and four patients had received 1 dose of 
measles vaccine; all patients had fever with the median fever of 39°C (range: 38.5–39.5), the median fever duration 
was 7 days. All patients had cough and rash, three patients had pneumonia complication and two patients had 
elevated liver transaminase levels. All patients had hospital visits or were hospitalized before measles onset, with 
the median time: 10 days (range: 7–24 days); all patients were likely to expose each other. All 11 patients recovered.
CONCLUSIONS: The measles outbreak was occurred among children with cancer, especially for children without 
prior measles vaccine or without two prior doses. Moreover, even children received two prior dose vaccine, their 
immunocompromised status caused them to be infected. There was not a different area for outpatient and inpatient 
in the hospital, so measles transmission occurred.
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Introduction
Measles is a viral infection that starts in the 
respiratory system. It is a highly contagious, serious 
disease and can be spread by direct contact, droplets, 
or airborne transmission. Measles symptoms appear 
7–14 days after contact with the virus and typically 
include high fever, cough, coryza, and conjunctivitis 
as well as a characteristic rash. Measles still remains 
a significant cause of death worldwide, despite the 
availability of a safe, effective vaccine [1].
There were about 110,000 global deaths 
related to measles in 2017, most of them in children 
under the age of 5, according to the World Health 
Organization source.
In Vietnam, there were 1,177 confirmed 
measles cases in 2018, twice as many cases as in 
2017. Most of the measles cases related to the lack of 
vaccination due to parents deciding to delay vaccination 
of their children. In late 2018, the Ministry of Health 
launched an additional measles-rubella vaccination 
campaign for 4.2 million children aged between 1 and 
5 in vulnerable areas in 57 cities and provinces [2]. 
UNICEF called on parents to make an extra effort to 
consult health official to ensure that their children’s 
immunization status is up to date to protect their children 
against the disease. UNICEF also advocated health 
authorities to sustain investment to build trust among the 
population and to focus on reaching the poorest, most 
marginalized communities, including internal migrant 
populations. Unexpected, measles outbreak occurred 
in immunocompromised children in some hospitals all 
over the world [3]. The immunocompromised children 
are not only at high risk of developing the severe 
vaccine-preventable infectious disease but may also 
serve as a reservoir for the transmission of pathogens 
in the susceptible population. In this study, we described 
the epidemiological features, clinical manifestation, and 
outcomes of 11 children with malignancies.
Patient and Method
Patients
All 11 measles children with malignancies 
were treated at Pediatric Center, Hue Central 
Hospital, Vietnam. Measles case was diagnosed 
based on both clinical manifestations and laboratory 
confirmation with the presence of measles-specific 
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immunoglobulin M (IgM) in serum, or possibly 
diagnosed based on clinical manifestations and 
measles endemic.
The present study was approved by the Hue 
Central Hospital Review Board and conducted in 
compliance with the ethical standards of the responsible 
institution on human subjects as well as with the Helsinki 
Declaration.
Laboratory investigations
For аll pаtients, the serum sаmples were 
collected аt the time of clinicаlly suspected of meаsle 
аnd these sаmples were delivered to the Depаrtment 
of Biochemistry of Hue Centrаl Hospitаl. IgM аntibody 
аgаinst meаsles virus wаs tested by enzyme-linked 
immunosorbent аssаys.
Furthermore, during the time patients were 
suffered from measles in hospital, all of the patients 
developed bacterial infection, especially respiratory 
infection, so eаch pаtient received а comprehensive 
lаborаtory investigаtion, including complete peripherаl 
blood cell count, C-reаctive protein (CRP), аnd chest 
X-rаy.
Dаtа collection
Dаtа were prospectively collected which were 
bаsed on the medicаl record during hospitаlizаtion, 
аnd dаtа аnаlysis wаs performed аnonymously. We 
collected demogrаphic feаtures, vаccinаtion stаtus, 
clinicаl symptoms аnd signs, lаborаtory findings, 
treаtment, аnd outcome.
Pneumonia was diagnosed based on both 
respiratory symptoms and chest X-ray images; the 
magnitude of aminotransferase alteration was defined 
based on the criteria [4]; neutropenia was diagnosed 
when the absolute neutrophils count (ANC) of peripheral 
blood was <0.5 × 109/l.
Statistical analysis
Data were analyzed with SPSS v.18.0 (IBM 
Corp., Armonk, NY, USA). Categorical variables were 
presented as frequency and continuous variable was 
computed for a median and a range.
Results
Epidemiology characteristic
From April 20 to July 10, in 2019, a total of 
11 oncology children were diagnosed measles with 
the median age of 4.0 years (range: 1–9 years), of 
these, there were 7 girls and 4 female/male = 1.74/1. 
The first case was a 13-month-old boy who was 
undergoing chemotherapy and irradiation and did 
not receive measles vaccine since he developed 
malignancy at the age of 8 months. There were seven 
patients appeared measles symptoms when they 
were in hospital, and they had been possibly exposed 
to each other. The other four measles children also 
visited the hospital for medical care 7–21 days before 
measles onset. Most of the patients (10/11) were 
admitted hospital and transferred to the pediatric 
infection department when they were suspected 
measles cases.
Measles vaccination status
Measles vaccination status was available 
in nine patients; two patients had not received any 
previous measles vaccine. Among the 9 vaccinated 
children, 4 cases had received one dose of vaccine 
and 5 cases had received two doses of vaccine. The 
interval between vaccination and onset of measles was 
more than 6 months.
Clinical characteristics
All of 11 patients had a fever with the median 
fever of 39°C (range: 38.5–39.5), the median fever 
duration was 7 days (range 3–13 days); 11 patients 
had cough; nine patients had coryza; seven patients 
had conjunctivitis; two patients had Koplik’s spot; 
Table 1: Symptoms of measles
Clinical signs Frequency
Fever 11
Cough 11
Rash 11
Conjunctivitis 7
Coryza 9
Koplik’s spot 2
and 11 patients had rash (Table 1). The median time 
to appear rash since onset was 4 days. Most of the 
patients, the appearance and sequence of rash were 
typical.
The types of underlying diseases included acute 
lymphoblastic leukemia in seven patients, neuroblastoma 
in one patient, and Wilms tumor in three patients. 
Nine patients developed measles when patients were 
ongoing chemotherapy, irradiation, or just completion of 
chemotherapy, and the remaining two patients did not 
receive chemotherapy during recent 1 month.
Of the 11 patients, there was one outpatient 
with very typical clinical manifestation; we did not check 
IgM antibody, five patients were positive for measles-
specific IgM antibody. One patient had neutropenia 
during the illness. The median WBC and ANC were 
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2.08 × 109/l and 1.27 × 109/l, respectively. The median 
CRP was 12.2 mg/dl (Table 2).
evidence can be used to guide this practice [10], [11]. 
The immunocompromised children are not only at 
high risk of developing severe vaccine-preventable in 
infectious disease but may also serve as a reservoir 
for the transmission of pathogens in susceptible 
populations. This can explain the transmission in our 
patients; at the beginning, there was one patient with 
measles, then there were 10 other patients exposed 
measles. Similarly, Ge showed that 20 patients were 
likely to be exposed to each other [3].
The median age in our patients was 4 years 
old (range: 1–8 years) which was smaller in Ge’s 
research: The median age was 5.5 years (range: 
11 months–14 years) [3]. Half of our patients were 
positive for measles-specific IgM antibody which was 
smaller than that in Ge’s research (95.7%) [3]. It can be 
explained the time we did the test too earlier, at the early 
stage of appearing rash, and we did not do the second 
measles-specific IgM test again if the first time test 
was negative. Some previous literature documented 
that the measles-specific IgM response may be either 
short lived or absent in vaccinated person [12], [13]. 
However, we could probably diagnose measles based 
on clinical symptoms and measles endemic. All of our 
patients had rash, fever, and cough; most patients had 
coryza, conjunctivitis, and a small patient had Koplik’s 
spot. Similarly, Ge showed that 43.5% of breakthrough 
measles in vaccinated immunocompromised children 
did not present Koplik’s spot [3]. All of our patients 
recovered without any death. Contrast to us, Ge 
showed 21.7% of patient died [3], Nakano reported 
one patient died [6]. It could be explained that in our 
research, these patients did not receive intensive 
chemotherapy before the measles attack and we 
followed up the patients carefully; in Ge’s research, 
those fatal patients received more prolonged and 
intensive chemotherapy for relapsed leukemia before 
measles attack.
Conclusions
The measles outbreak was occurred among 
children with cancer, especially for children without 
prior measles vaccine or without two prior doses. 
Moreover, even children received two prior dose 
vaccine, their immunocompromised status caused 
them to be infected. There was not a different 
area for outpatient and inpatient in the hospital, 
so measles transmission occurred. Following this 
measles outbreak, a designated outpatient area was 
established to limit inpatient exposures and hospital 
transmission.
Table 2: The result of blood tests
Laboratory investigations Median Range 
CRP 12.2 mg/dl 2.2–171.0 mg/dl
WBC 2.08×109/l 0.67–6.04×109/l
Neutrophile 1.27×109/l 0.07–3.51×109/l
Hb 10.0 g/dl 7.4–12.2 g/dl
PLT 150×109/l 100–460×109/l
CRP: C-reactive protein, WBC: White blood cell, Hb: Hemoglobin, PLT: Platelet.
Treatment and outcomes
Of the 11 patients, three patients had 
pneumonia, eight patients had bronchitis, one patient 
had diarrhea, and two patients had marked increase 
in aminotransferase level. Only one patient had 
neutropenia, and ANC recovered slowly due to she got 
pneumonia and had to use antibiotics combined with 
antifungal. All of the patients used antibiotics, in which 
there were two patients who received oral antibiotics. 
All of the patients recovered.
Discussion
In our study reported the measles outbreak 
in pediatric patients with malignancies during the 
measles epidemic in Vietnam. Similarly, Ge described 
the measles outbreak in pediatric patients with 
malignancies and post-HSCT during the measles 
epidemic in China [3], Nakano and Kaplan described 
clinical features of measles in immunocompromised 
children [5], [6]. Our first case was the same first 
case in Ge’s research: Both cases were undergoing 
chemotherapy and did not receive the measles 
vaccine since they developed malignancy at a very 
young age before the age to receive the measles 
vaccine [3]. The rate of vaccinated patients (1–2 
doses of measles) was 9/11, which was smaller than 
the rate of vaccinated patients in Ge’s research: 
95.6%. This was a factor make our patients to be 
easier to expose measles. Chemotherapy-induced 
immune suppression may result in significant 
loss of pre-existing protective antibodies against 
vaccine antigens due to long-term impairment of 
humoral immunity in cancer patients and other 
immunocompromised populations [7], [8], [9]. At 
present, it is recommended that cancer patients 
could be immunized or reimmunized at appropriate 
intervals to reduce the risk of vaccine-preventable 
infection [10], [11]. However, live vaccines 
administrations are usually contraindicated to cancer 
patients during chemotherapy and are recommended 
to be administered to cancer patients 3–6 months after 
cancer chemotherapy. Hence, it is difficult to balance 
the risk and benefit of revaccination for patients during 
chemotherapy in an outbreak setting and no existing 
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